Literature DB >> 35363458

Da Vinci SP radical prostatectomy: a multicentric collaboration and step-by-step techniques.

Marcio Covas Moschovas1,2, Isabella Brady1, Abdel Rahman Jaber1, Mahmoud Abou Zeinab3, Aaron Kaviani3, Jihad Kaouk3, Simone Crivellaro4, Jean Joseph5, Alexandre Mottrie6, Vipul Patel1,2.   

Abstract

INTRODUCTION: Several techniques of robotic-assisted radical prostatectomy (RARP) using the da Vinci SP (SP) have been described since its clearance by the FDA (Food and Drug Administration) in 2018 (1, 2). Even with the expanding literature about this robot, the SP technology has been restricted to a few centers in the US and Asia due to the recent release of this robot in the marked.3 In this scenario, we provided, in this video compilation, a consensus of SP referral centers describing the current approaches and techniques of da Vinci SP Radical prostatectomy (SP-RARP). SURGICAL TECHNIQUE: We have illustrated five different techniques, including transperitoneal, extraperitoneal, Retzius-sparing, transvesical, and transperineal (4-6). Each surgery demonstrated crucial steps from the trocar placement until anastomosis. All approaches follow anatomic concepts and landmarks to minimize positive surgical margins, optimize oncological outcomes and promote optimal functional recovery. The trocar placement and the use of an assistant port were selected according to the operative technique of each institution. None of these surgeries had intra- or postoperative complications, and the pain management until discharge was controlled without using narcotics. All patients were discharged in less than 16 hours of surgery.
CONCLUSION: Robotic-assisted radical prostatectomy performed with the da Vinci SP is feasible and safe with optimal perioperative outcomes. Five different approaches were described in this video compilation, and we believe that the technical details provided by this multicentric collaboration are crucial for centers willing to initiate the SP approach to radical prostatectomy. Copyright® by the International Brazilian Journal of Urology.

Entities:  

Mesh:

Year:  2022        PMID: 35363458      PMCID: PMC9306363          DOI: 10.1590/S1677-5538.IBJU.2022.99.15

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   3.050


  6 in total

Review 1.  Minimizing minimally invasive surgery: Current status of the single-port robotic surgery in Urology.

Authors:  J Garisto; R Bertolo; S W Reese; P Bove; J Kaouk
Journal:  Actas Urol Esp (Engl Ed)       Date:  2021-05-14

2.  Applications of the da Vinci single port (SP) robotic platform in urology: a systematic literature review.

Authors:  Marcio Covas Moschovas; Seetharam Bhat; Travis Rogers; David Thiel; Fikret Onol; Shannon Roof; Maria C Sighinolfi; Bernardo Rocco; Vipul Patel
Journal:  Minerva Urol Nephrol       Date:  2020-09-29

3.  Single-Port Retzius-Sparing Robot-Assisted Radical Prostatectomy: Feasibility and Early Outcomes.

Authors:  Jeffrey C Bassett; Salpi Salibian; Simone Crivellaro
Journal:  J Endourol       Date:  2022-01-12       Impact factor: 2.942

4.  Implementing the da Vinci SP Without Increasing Positive Surgical Margins: Experience and Pathologic Outcomes of a Prostate Cancer Referral Center.

Authors:  Marcio Covas Moschovas; Sarah Kind; Seetharam Bhat; Jonathan Noel; Marco Sandri; Travis Rogers; Daniel Moser; Isabella Brady; Vipul Patel
Journal:  J Endourol       Date:  2022-04       Impact factor: 2.942

Review 5.  Single-port technique evolution and current practice in urologic procedures.

Authors:  Marcio Covas Moschovas; Kulthe Ramesh Seetharam Bhat; Fikret Fatih Onol; Travis Rogers; Gabriel Ogaya-Pinies; Shannon Roof; Vipul R Patel
Journal:  Asian J Urol       Date:  2020-05-22

6.  Single-Port Percutaneous Transvesical Simple Prostatectomy Using the SP Robotic System: Initial Clinical Experience.

Authors:  J Kaouk; G Sawczyn; C Wilson; A Aminsharifi; K Fareed; J Garisto; L Lenfant
Journal:  Urology       Date:  2020-03-11       Impact factor: 2.649

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.